Survivorship clinic — integrated survivorship and MDT station

Communication and integrated-care station on gynaecological cancer survivorship: tests the structured survivorship assessment, the sexual-function restorative ladder, lymphoedema and premature-menopause management, evidence-based surveillance reasoning, fear-of-recurrence communication, and activation of the multidisciplinary team. Includes assessor key and marking domains.

Prompt

A 50-year-old woman is eleven months out from concurrent chemoradiotherapy for FIGO 2018 stage IIB cervical cancer. Her surveillance vault review, pelvic MRI and PET-CT are clear. She tells you, only when asked, that intercourse is now too painful to continue, her left leg aches and swells by evening, hot flushes wreck her sleep, and she is convinced the cancer is returning. You are the gynaecology registrar; the consultant and the MDT are available.

Station brief

Format. Communication and integrated-care station, approximately 12 minutes. You are the gynaecology registrar in a survivorship clinic. A specialist cancer nurse is with you; the consultant and the full multidisciplinary team are available by referral. The assessor will run the clock and probe your management. ^[1]

Candidate instruction. Conduct the survivorship visit: confirm disease status, assess and manage her late effects, justify her surveillance, address her psychological distress, and activate the multidisciplinary team. Verbalise your reasoning and your communication. ^[1]

References7Show

[1]Mayer DK, Nekhlyudov L, Snyder CF, et al. American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning J Oncol Pract, 2014.PMID 25316025
[2]Hathout L, Zhang Y, Lymberis S, et al. A Systematic Review of Patient-Reported Outcomes on the Impact of Radiation Therapy on Sexual Health in Patients With Gynecologic Cancer Int J Radiat Oncol Biol Phys, 2026.PMID 41720168
[3]Martins J, Vaz AF, Grion RC, et al. Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial BMC Cancer, 2021.PMID 34112100
[4]Law E, Kelvin JF, Thom B, et al. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy Radiother Oncol, 2015.PMID 26164775
[5]Kurtuluş D, Arkan K, Suçeken FY, et al. Pelvic Floor Dysfunction Following Gynecologic Cancer Surgery and Adjuvant Therapy: Epidemiology, Mechanisms, and Management-A Systematic Review Int Urogynecol J, 2026.PMID 41579191
[6]Akizuki N, Yamawaki S, Akechi T, et al. Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients J Pain Symptom Manage, 2005.PMID 15652442
[7]Sessa C, Travado L, Calaminus G, et al. European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team Tumori, 2025.PMID 39643948

Survivorship clinic — integrated survivorship and MDT station

Station brief

References7Show

[1]Mayer DK, Nekhlyudov L, Snyder CF, et al. American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning J Oncol Pract, 2014.PMID 25316025
[2]Hathout L, Zhang Y, Lymberis S, et al. A Systematic Review of Patient-Reported Outcomes on the Impact of Radiation Therapy on Sexual Health in Patients With Gynecologic Cancer Int J Radiat Oncol Biol Phys, 2026.PMID 41720168
[3]Martins J, Vaz AF, Grion RC, et al. Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial BMC Cancer, 2021.PMID 34112100
[4]Law E, Kelvin JF, Thom B, et al. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy Radiother Oncol, 2015.PMID 26164775
[5]Kurtuluş D, Arkan K, Suçeken FY, et al. Pelvic Floor Dysfunction Following Gynecologic Cancer Surgery and Adjuvant Therapy: Epidemiology, Mechanisms, and Management-A Systematic Review Int Urogynecol J, 2026.PMID 41579191
[6]Akizuki N, Yamawaki S, Akechi T, et al. Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients J Pain Symptom Manage, 2005.PMID 15652442
[7]Sessa C, Travado L, Calaminus G, et al. European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team Tumori, 2025.PMID 39643948